Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods1. Issue 18 (4th March 2015) - Ordanini, Stefania
Abstract Rational design of DC-SIGN antagonists combines a selective glycomimetic ligand with trivalent dendrons spaced by a rigid core and allows to exploit multiple multivalency effects.